Grant DR - Search Results

1

The FGL2-FcgammaRIIB pathway: a novel mechanism leading to immunosuppression.

Liu H, Shalev I, Manuel J, He W, Leung E, Crookshank J, Liu MF, Diao J, Cattral M, Clark DA, Isenman DE, Gorczynski RM, Grant DR, Zhang L, Phillips MJ, Cybulsky MI, Levy GA. Liu H, et al. Among authors: grant dr. Eur J Immunol. 2008 Nov;38(11):3114-26. doi: 10.1002/eji.200838338. Eur J Immunol. 2008. PMID: 18991288 Free article.

2

Potential for CsA-Neoral in organ transplantation.

Levy G, Grant D. Levy G, et al. Transplant Proc. 1994 Oct;26(5):2932-4. Transplant Proc. 1994. PMID: 7940926 Review. No abstract available.

3

Cyclosporine Neoral in liver transplant recipients.

Levy G, Rochon J, Freeman D, Wong PY, Banks L, Roach C, Engel K, Grant D. Levy G, et al. Transplant Proc. 1994 Oct;26(5):2949-52. Transplant Proc. 1994. PMID: 7940930 Clinical Trial. No abstract available.

4

Neoral in liver transplantation.

Levy GA, Grant D. Levy GA, et al. Transplant Proc. 1996 Apr;28(2):1019-21. Transplant Proc. 1996. PMID: 8623216 Review.

5

Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group.

Grant D, Rochon J, Levy G. Grant D, et al. Transplant Proc. 1996 Aug;28(4):2232-3. Transplant Proc. 1996. PMID: 8769208 Clinical Trial. No abstract available.

6

Strategies to prevent thrombosis in xenotransplants.

Levy GA, Marsden P, Zhong R, Cole EH, Grant D. Levy GA, et al. Transplant Proc. 1998 Aug;30(5):2458-60. doi: 10.1016/s0041-1345(98)00685-x. Transplant Proc. 1998. PMID: 9723536 Review.

7

[A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].

Roy A, Grant DR, Kneteman NM, Tchervenkov JI, Levy GA, Tan A, Hendricks L. Roy A, et al. Among authors: grant dr. Ann Chir. 1998;52(8):716-21. Ann Chir. 1998. PMID: 9846420 Clinical Trial. French.

8

CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection.

Gao JX, Madrenas J, Zeng W, Cameron MJ, Zhang Z, Wang JJ, Zhong R, Grant D. Gao JX, et al. Immunology. 1999 Oct;98(2):159-70. doi: 10.1046/j.1365-2567.1999.00863.x. Immunology. 1999. PMID: 10540214 Free PMC article.

9

Pharmacokinetics and tolerability of 40-0-[2-hydroxyethyl]rapamycin in de novo liver transplant recipients.

Levy GA, Grant D, Paradis K, Campestrini J, Smith T, Kovarik JM. Levy GA, et al. Transplantation. 2001 Jan 15;71(1):160-3. doi: 10.1097/00007890-200101150-00028. Transplantation. 2001. PMID: 11211186

10

Xenotransplantation: just around the corner?

Grant D, Mendicino M, Levy G. Grant D, et al. Surgery. 2001 Mar;129(3):243-7. doi: 10.1067/msy.2001.118380. Surgery. 2001. PMID: 11231451 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters